Posted on

Body of Evidence: Thymidine Kinase Type 1

Biomarker for Cancer

Clinical Applications and Research

We’re excited to bring you the newest Growing Body of Evidence: Thymidine Kinase.

Research in support of TK1 as a biomarker for cancer detection and monitoring continues to mount. The Growing Body of Evidence provides a summary of that research, and applications for use in your practice.

Click to download, or learn more below.

TK1 is available in the following tests/panels from VDI:

  • Wellness Panels + Cancer Risk
  • Canine Cancer Panel
  • Pericardial Effusion Panel (PCE)
  • Feline Cancer Panel
  • Pre-Stem Cell Therapy Panel
  • Equine TK1



  • Lymphoma
  • Abdominal Masses
  • Hypercalcemia of malignancy
  • ADR
  • Stem Cell Therapy
  • Metastatic Disease
  • Therapeutic Monitoring
  • Pericardial Effusion Tumor Dx
  • Wellness Screening


  • GI Lymphoma vs IBD
  • Therapeutic Monitoring
  • Metastatic Disease


  • Lymphoma